Dementia: Doctors warned to stop giving the wrong drugs

Elderly people with dementia are regularly being given drugs that they shouldn’t be taking – and which are too often killing them.

Dementia patients are regularly prescribed anti-psychotic drugs in order to control their behaviour – but this week America’s drug regulator, the Food and Drug Administration (FDA), has finally warned doctors to stop the practice.

Several studies have found that this ‘off-label’ prescribing – where drugs are used to treat diseases for which they were not originally intended – has resulted in the deaths of patients. 

Using new powers, the FDA has instructed the manufacturers of ‘conventional and ‘atypical’ antipsychotics to change their prescribing instructions so that dementia patients no longer get the drugs. 

Drugs that are affected include Risperdal (risperidone), Seroquel (quetiapine), Zyprexa (olanzapine), and Thorazine (chlorpromazine).

(Source: FDA website; http://www.fda.gov/bbs/topics/NEWS/2008/NEW01851.html)

Related WDDTY Content

Antipsychotic Drugs - Olanzapine

Q My wife and daughter were both put onto olanzapine (Zyprexa) last year, having been prescribed other antipsychotic drugs for 30 and 10 years, respec...

Risperdal

Risperdal (risperidone) is the most prescribed antipsychotic in the US and, with worldwide sales of $2.1bn, is Johnson & Johnson’s second most profita...

Antipsychotics increase death risk in elderly

The maverick practice of off-label prescribing - giving drugs for unapproved conditions/patients - is once again in the limelight. The US Food and Dru...

anti psychotic drugs useful for some psychosis

I was probably the first British author to pioneer a nutritional approach to schizophrenia.

Dementia: - The drugs don't work, but so much can

Medicine's standard response to dementia is a prescription drug, ranging from an antipsychotic, an antidepressant or a mood stabilizer. But a new stu...

Antipsychotic: Eli Lilly suppresses data that reveals drug’s danger, papers claim

Sensitive documents that suggest the drug maker Eli Lilly has been suppressing vital safety information about its best-selling antipsychotic Zyprexa (...